---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-046079"
form_type: "8-K"
ticker: "RMTG"
cik: "0001760026"
company_name: "Regenerative Medical Technology Group Inc."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:17:11.618690+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Meso Numismatics reports positive operating cash flow >$100k in Q1 2024; proceeding with name change to RMTG

## Summary
- Name change to Regenerative Medical Technology Group Inc. pending FINRA market effective date.
- Positive cash from operations over $100k for the quarter ended March 31, 2024, per recent 10-Q.
- New logo and authorized shares change near completion to reflect biotech focus.
- Company transitions from numismatics to regenerative medicine, now a stem cell company.

## SEC filing metadata
- accession: 0001213900-24-046079
- form_type: 8-K
- ticker: RMTG
- cik: 0001760026
- company_name: Regenerative Medical Technology Group Inc.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760026/000121390024046079/0001213900-24-046079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760026/000121390024046079/ea0206745-8k_mesonum.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-046079
- JSON: https://secwatch.observer/filing/0001213900-24-046079.json
- Plain text: https://secwatch.observer/filing/0001213900-24-046079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.